Y8C-33091-61781

4 vaccinations 9 coded responses 38 check-ins 9 free-text entries 1 call case

Sex: Female
Age at first dose: 36-40
ZIP prefix: 982 / WA
Registered: 2021-04-06

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-04-05
Dose 1 — Pfizer-BioNTech
2021-04-06
Registered in v-safe
2021-04-06
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2021-04-07
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2021-04-08
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2021-04-09
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-04-10
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-04-11
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Fatigue or tiredness

Adult check-in
2021-04-12
Health check-in — day 7, dose 1
Feeling: Good · Fatigue or tiredness

Adult check-in
2021-04-19
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-04-26
Dose 2 — Pfizer-BioNTech
2021-04-26
Health check-in — day 0, dose 2
Feeling: Good · Site: Pain · None

Adult check-in
2021-04-27
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Fever · Headache, Joint pains, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2021-04-28
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2021-04-29
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Fatigue or tiredness

Adult check-in
2021-04-30
Health check-in — days 1–6 daily, dose 2
Feeling: Poor · Headache, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2021-05-01
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Headache, Fatigue or tiredness

Adult check-in
2021-05-02
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Headache, Fatigue or tiredness

Adult check-in
2021-05-03
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-05-10
Survey response — day 14, dose 2
MedDRA: Brain fog, Diarrhoea, Fatigue, Insomnia, Nausea — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities

Free text: Sleeplessness, diarrhea, fatigue, nausea, brain fog

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-17
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-05-24
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-05-31
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-06-07
Survey response — day 42, dose 2
MedDRA: Abdominal distension, Diarrhoea, Discomfort, Flatulence, Gastrointestinal disorder, Headache, Migraine, Pain — Feeling: Good · Be unable to do your normal daily activities

Free text: Essentially, ever since my second shot I have had persistent headache, migraine, and GI concerns at elevated levels and/or more frequent incidents than my status quo. GI concerns include diarrhea, gas/bloating, and pain/discomfort.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-07-26
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-10-25
Health check-in — 6 months, dose 2
Feeling: Fair

Adult check-in
2021-11-22
Dose 3 — Pfizer-BioNTech
2022-04-26
Survey response — 12 months, dose 2
MedDRA: Headache, Migraine, Pre-existing disease — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Increase in headaches. My quarterly IV infusion of migraine prevention drug Vyepti has had limited effectiveness since getting my second vaccine shot in Apr 2021 and booster in Nov 2021.

MedDRA releases: 2024-11 · check-in free text available
2022-07-08
Dose 4 — Moderna
2022-07-09
Health check-in — days 1–6 daily, dose 4
Feeling: Poor · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Adult check-in
2022-07-09
Report sent to call center — days 1–6 daily, dose 4
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-07-10
Health check-in — days 1–6 daily, dose 4
Feeling: Fair · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities

Adult check-in
2022-07-11
Survey response — days 1–6 daily, dose 4
MedDRA: Unevaluable event — Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Sinuses

MedDRA releases: 2024-11 · check-in free text available
2022-07-11
Call successful
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
2022-07-12
Survey response — days 1–6 daily, dose 4
MedDRA: Ear pain, Neck pain, Pain of skin, Sinusitis — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Sinus infection, scalp pain, ear pain, neck pain

MedDRA releases: 2024-11 · check-in free text available
2022-07-13
Survey response — days 1–6 daily, dose 4
MedDRA: Unevaluable event — Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school

Free text: Sinus

MedDRA releases: 2024-11 · check-in free text available
2022-07-14
Survey response — days 1–6 daily, dose 4
MedDRA: Unevaluable event — Feeling: Fair · Headache, Fatigue or tiredness · Be unable to work or attend school

Free text: Sinus

MedDRA releases: 2024-11 · check-in free text available
2022-07-15
Survey response — day 7, dose 4
MedDRA: Unevaluable event — Feeling: Fair · Headache, Fatigue or tiredness

Free text: Sinus

MedDRA releases: 2024-11 · check-in free text available
2022-07-22
Health check-in — day 14, dose 4
Feeling: Fair

Adult check-in
2022-07-29
Health check-in — day 21, dose 4
Feeling: Good

Adult check-in
2022-08-05
Health check-in — day 28, dose 4
Feeling: Good

Adult check-in
2022-08-12
Survey response — day 35, dose 4
MedDRA: Back pain, COVID-19, Cough, Muscle spasms, Musculoskeletal chest pain — Feeling: Good · Be unable to do your normal daily activities

Free text: Muscle spasms have persisted after Covid illness (started after receding from cough and resuming an upright life instead of supine on couch). Recently pain has increased in my ribs and back.

MedDRA releases: 2024-11 · check-in free text available
2022-08-19
Health check-in — day 42, dose 4
Feeling: Good

Adult check-in
2022-10-07
Health check-in — 3 months, dose 4
Feeling: Good

Adult check-in
2023-01-06
Health check-in — 6 months, dose 4
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-04-05	Pfizer-BioNTech
2	2021-04-26	Pfizer-BioNTech
3	2021-11-22	Pfizer-BioNTech	No
4	2022-07-08	Moderna	No

Call center

Reported	Outcome	VAERS-related outcome
2022-07-09	Successful 2022-07-11	Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill

Free text

Release 8 — day 14, dose 2

2021-05-10

Symptoms: Sleeplessness, diarrhea, fatigue, nausea, brain fog

Release 8 — day 42, dose 2

2021-06-07

Symptoms: Essentially, ever since my second shot I have had persistent headache, migraine, and GI concerns at elevated levels and/or more frequent incidents than my status quo. GI concerns include diarrhea, gas/bloating, and pain/discomfort.

Release 11 — 12 months, dose 2

2022-04-26

Symptoms: Increase in headaches. My quarterly IV infusion of migraine prevention drug Vyepti has had limited effectiveness since getting my second vaccine shot in Apr 2021 and booster in Nov 2021.

Release 12 — days 1–6 daily, dose 4

2022-07-11

Systemic reaction (other): Sinuses

2022-07-12

Systemic reaction (other): Sinus infection, scalp pain, ear pain, neck pain

2022-07-13

Systemic reaction (other): Sinus

2022-07-14

Systemic reaction (other): Sinus

Release 12 — day 7, dose 4

2022-07-15

Systemic reaction (other): Sinus

Release 12 — day 35, dose 4

2022-08-12

Symptoms: Muscle spasms have persisted after Covid illness (started after receding from cough and resuming an upright life instead of supine on couch). Recently pain has increased in my ribs and back.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Abdominal distension	✓	✓	✓
SD	Back pain	·	·	✓
SD	Brain fog	✓	✓	✓
SD	Cough	·	·	✓
SD	COVID-19	·	·	✓
SD	Diarrhoea	✓	✓	✓
SD	Discomfort	✓	✓	✓
SD	Fatigue	✓	✓	✓
SD	Flatulence	✓	✓	✓
SD	Gastrointestinal disorder	✓	✓	✓
SD	Headache	✓	✓	✓
SD	Insomnia	✓	✓	✓
SD	Migraine	✓	✓	✓
SD	Muscle spasms	·	·	✓
SD	Musculoskeletal chest pain	·	·	✓
SD	Nausea	✓	✓	✓
SD	Pain	✓	✓	✓
SD	Pre-existing disease	·	·	✓
SRO	Ear pain	·	·	✓
SRO	Neck pain	·	·	✓
SRO	Pain of skin	·	·	✓
SRO	Sinusitis	·	·	✓
SRO	Unevaluable event	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release